SFA
STAB

Sequoia Financial Advisors’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Sequoia Financial Advisors’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-12,588
Closed -$69K – 479
2021
Q2 		$69K Buy
+12,588
New +$67.8K ﹤0.01% 471

Other funds holding STAB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DY
Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Sequoia Financial Advisors's STAB Position: Q3 2021 in Review

Sequoia Financial Advisors sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q3 2021, closing a stake of 12,588 shares — an estimated $69K sold.

Sequoia Financial Advisors first reported a position in STAB in Q2 2021 and held it in 1 quarter. The position peaked at $69K in Q2 2021. 23 funds tracked by Wall St. Rank hold STAB as of Q3 2021.

  • Sequoia Financial Advisors reported no remaining Statera Biopharma, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Sequoia Financial Advisors sold 12,588 Statera Biopharma, Inc. Common Stock shares in Q3 2021, an estimated $69K.
  • Sequoia Financial Advisors first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Sequoia Financial Advisors's Statera Biopharma, Inc. Common Stock position peaked at $69K in Q2 2021.
  • 23 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q3 2021.

Based on Sequoia Financial Advisors's 13F filing for Q3 2021, filed 26 Oct 2021.